Enhancing hiPSC culture quality with Recombinant Insulin supplementation

Case study: Recombinant insulin

Background

The advent of human induced pluripotent stem cells (hiPSCs) has revolutionized the field of regenerative medicine by enabling the creation of patient-specific cells from any lineage. To ensure the consistent and reliable production of high-quality hiPSCs, adherence to current good manufacturing practice (cGMP) protocols is crucial. This study delves into the benefits of incorporating Recombinant Insulin in hiPSC culture to further enhance the quality and productivity of these cells.

Study description and results 

To assess the impact of Recombinant Insulin on hiPSC cell culture, we examined changes in cell morphology, cell proliferation, cell attachment, and the expression of pluripotency markers.

Download the entire study

Sara Bursomanno
Sara Bursomanno
Global Product Manager

Phone: +45 31970096
Email: usbu@novonordisk.com